drugset / Trial / NCT05711641

Action of Intra-auricular Topical Lidocaine on Tinnitus

NCT05711641 ↗

RandomizedCrossoverDouble-blindDiagnostic

Summary

The main objective of this clinical trial placebo controled is to evaluate the action of intraauricular topical lidocaine on tinnitus. The question to be answered is whether lidocaine is superior to placebo (distilled water) in reducing tinnitus intensity when applied topically within the external auditory canal. Tinnitus intensity will be measured using the visual analog scale and acuphenometry before and after lidocaine or placebo application.

Timeline

Start
2022-09-02
Primary completion
2023-06-01
Completion
2023-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 10 mg/ml Topical

Indications